Skip to main content
. 2017 Jul 31;8(48):83817–83830. doi: 10.18632/oncotarget.19745

A.

Patient number 1 31 34
Age 16 46 20
Diagnosis-to-transplant interval [m] 50 7 100
Donor-recipient HLA mismatched 3 4 5
Infused MNC cells(8×108/kg) 7.5 7.1 8.7
Rejection type Rej Rej Rej
Comment 2 HFD-HSCT 2 HFD-HSCT 2 HFD-HSCT
Autologous recovery No No No
Alive(A)/Death(D), reason D/CMV-IPn A A
Follow-up [m] 5 18 9
Transfusion dependent - No No